|
1
|
Oser MG, Niederst MJ, Sequist LV and
Engelman JA: Transformation from non-small-cell lung cancer to
small-cell lung cancer: Molecular drivers and cells of origin.
Lancet Oncol. 16:e165–e172. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mornex F and Girard N: Gemcitabine and
radiation therapy in non-small cell lung cancer: State of the art.
Ann Oncol. 17:1743–1747. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Osugi J, Muto S, Matsumura Y, Higuchi M,
Suzuki H and Gotoh M: Prognostic impact of the high-sensitivity
modified Glasgow prognostic score in patients with resectable
non-small cell lung cancer. J Cancer Res Ther. 12:945–951. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Novaes FT, Cataneo DC, Ruiz Junior RL,
Defaveri J, Michelin OC and Cataneo AJ: Lung cancer: Histology,
staging, treatment and survival. J Bras Pneumol. 34:595–600. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shenouda SK and Alahari SK: MicroRNA
function in cancer: Oncogene or a tumor suppressor? Cancer
Metastasis Rev. 28:369–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yao Y, Suo AL, Li ZF, Liu LY, Tian T, Ni
L, Zhang WG, Nan KJ, Song TS and Huang C: MicroRNA profiling of
human gastric cancer. Mol Med Rep. 2:963–970. 2009.PubMed/NCBI
|
|
8
|
Sui CJ, Xu F, Shen WF, Dai BH, Lu JJ,
Zhang MF and Yang JM: MicroRNA-147 suppresses human hepatocellular
carcinoma proliferation migration and chemosensitivity by
inhibiting HOXC6. Am J Cancer Res. 6:2787–2798. 2016.PubMed/NCBI
|
|
9
|
Chu G, Zhang J and Chen X: Serum level of
microRNA-147 as diagnostic biomarker in human non-small cell lung
cancer. J Drug Target. 24:613–617. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Zhao M, Liu J, Sun Z, Ni J and Liu
H: miRNA-125b regulates apoptosis of human non-small cell lung
cancer via the PI3K/Akt/GSK3β signaling pathway. Oncol Rep.
38:1715–1723. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Teng P, Jiao Y, Hao M and Tang X:
microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to
inhibit development of cervical cancer via down-regulating PARP2. J
Cell Biochem. 119:5243–5252. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee CG, McCarthy S, Gruidl M, Timme C and
Yeatman TJ: MicroRNA-147 induces a mesenchymal-to-epithelial
transition (MET) and reverses EGFR inhibitor resistance. PLoS One.
9:e845972014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
McAllister AK: Neurotrophins and neuronal
differentiation in the central nervous system. Cell Mol Life Sci.
58:1054–1060. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sandhya VK, Raju R, Verma R, Advani J,
Sharma R, Radhakrishnan A, Nanjappa V, Narayana J, Somani BL,
Mukherjee KK, et al: A network map of BDNF/TRKB and BDNF/p75NTR
signaling system. J Cell Commun Signal. 7:301–307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
De la Cruz-Morcillo MA, Berger J,
Sánchez-Prieto R, Saada S, Naves T, Guillaudeau A, Perraud A,
Sindou P, Lacroix A, Descazeaud A, et al: p75 neurotrophin receptor
and pro-BDNF promote cell survival and migration in clear cell
renal cell carcinoma. Oncotarget. 7:34480–34497. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang SM, Lin C, Lin HY, Chiu CM, Fang CW,
Liao KF, Chen DR and Yeh WL: Brain-derived neurotrophic factor
regulates cell motility in human colon cancer. Endocr Relat Cancer.
22:455–464. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Okamura K, Harada T, Wang S, Ijichi K,
Furuyama K, Koga T, Okamoto T, Takayama K, Yano T and Nakanishi Y:
Expression of TrkB and BDNF is associated with poor prognosis in
non-small cell lung cancer. Lung Cancer. 78:100–106. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang SY, Hui LP, Li CY, Gao J, Cui ZS and
Qiu XS: More expression of BDNF associates with lung squamous cell
carcinoma and is critical to the proliferation and invasion of lung
cancer cells. BMC Cancer. 16:1712016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shen J, Niu W and Zhang H, Jun M and Zhang
H: Downregulation of microRNA-147 inhibits cell proliferation and
increases the chemosensitivity of gastric cancer cells to
5-fluorouracil by directly targeting PTEN. Oncol Res. 26:901–911.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ning X, Wang C, Zhang M and Wang K:
Ectopic expression of miR-147 inhibits stem cell marker and
epithelial-mesenchymal transition (EMT)-related protein expression
in colon cancer cells. Oncol Res. 27:399–406. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang Y, Zhang HE and Liu Z: MicroRNA-147
suppresses proliferation, invasion and migration through the
AKT/mTOR signaling pathway in breast cancer. Oncol Lett.
11:405–410. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ke Y, Zhao W, Xiong J and Cao R: miR-149
inhibits non-small-cell lung cancer cells EMT by targeting FOXM1.
Biochem Res Int. 2013:5067312013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang C, Liu E, Li W, Cui J and Li T:
miR-3188 inhibits non-small cell lung cancer cell proliferation
through FOXO1-mediated mTOR-p-PI3K/AKT-c-JUN signaling pathway.
Front Pharmacol. 9:13622018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Samuels Y, Wang Z, Bardelli A, Silliman N,
Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ, et al:
High frequency of mutations of the PIK3CA gene in human cancers.
Science. 304:5542004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Datta SR, Brunet A and Greenberg ME:
Cellular survival: A play in three Akts. Genes Dev. 13:2905–2927.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xia H, Li Y and Lv X: MicroRNA-107
inhibits tumor growth and metastasis by targeting the BDNF-mediated
PI3K/AKT pathway in human non-small lung cancer. Int J Oncol.
49:1325–1333. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kang HJ, Kim JM, Kim SY, Kim SW, Shin IS,
Kim HR, Park MH, Shin MG, Yoon JH and Yoon JS: A longitudinal study
of BDNF promoter methylation and depression in breast cancer.
Psychiatry Investig. 12:523–531. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tanaka K, Okugawa Y, Toiyama Y, Inoue Y,
Saigusa S, Kawamura M, Araki T, Uchida K, Mohri Y and Kusunoki M:
Brain-derived neurotrophic factor (BDNF)-induced
tropomyosin-related kinase B (Trk B) signaling is a potential
therapeutic target for peritoneal carcinomatosis arising from
colorectal cancer. PLoS One. 9:e964102014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Long J, Jiang C, Liu B, Fang S and Kuang
M: MicroRNA-15a-5p suppresses cancer proliferation and division in
human hepatocellular carcinoma by targeting BDNF. Tumour Biol.
37:5821–5828. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li W, Li X, Xin X, Kan PC and Yan Y:
MicroRNA-613 regulates the expression of brain-derived neurotrophic
factor in Alzheimer's disease. Biosci Trends. 10:372–377. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang P, Meng X, Huang Y, Lv Z, Liu J, Wang
G, Meng W, Xue S, Zhang Q, Zhang P, et al: MicroRNA-497 inhibits
thyroid cancer tumor growth and invasion by suppressing BDNF.
Oncotarget. 8:2825–2834. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ding D, Hou R, Gao Y and Feng Y: miR-613
inhibits gastric cancer progression through repressing brain
derived neurotrophic factor. Exp Ther Med. 15:1735–1741.
2018.PubMed/NCBI
|
